Yong Lu

3.4k total citations · 1 hit paper
53 papers, 2.6k citations indexed

About

Yong Lu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yong Lu has authored 53 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 30 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Yong Lu's work include Immune Cell Function and Interaction (15 papers), CAR-T cell therapy research (14 papers) and Immunotherapy and Immune Responses (10 papers). Yong Lu is often cited by papers focused on Immune Cell Function and Interaction (15 papers), CAR-T cell therapy research (14 papers) and Immunotherapy and Immune Responses (10 papers). Yong Lu collaborates with scholars based in United States, China and New Zealand. Yong Lu's co-authors include Qing Yi, Jianfei Qian, Enguang Bi, Xingzhe Ma, Qiang Wang, Yuhuan Zheng, Chengyun Zheng, Maojie Yang, Lintao Liu and Matthew F. Kalady and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yong Lu

52 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

2019 697 citations Xingzhe Ma, Enguang Bi et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yong Lu United States	24	1.3k	1.0k	949	512	275	53	2.6k
Fawzi Aoudjit Canada	28	862 0.7×	1.0k 1.0×	1.2k 1.3×	567 1.1×	146 0.5×	61	2.7k
Chengyun Zheng China	28	1.1k 0.9×	680 0.7×	855 0.9×	429 0.8×	227 0.8×	71	2.6k
Ines Gütgemann Germany	25	1.2k 0.9×	1.1k 1.1×	1.3k 1.4×	368 0.7×	332 1.2×	60	3.0k
Vinit Kumar United States	21	2.9k 2.3×	1.6k 1.5×	1.1k 1.1×	489 1.0×	240 0.9×	26	4.1k
Yasuto Akiyama Japan	27	708 0.6×	937 0.9×	878 0.9×	332 0.6×	270 1.0×	128	2.2k
Jennifer L. Guerriero United States	19	1.2k 0.9×	1.2k 1.2×	1.0k 1.1×	311 0.6×	249 0.9×	50	2.5k
Laura Strauss United States	29	3.2k 2.5×	2.0k 2.0×	1.1k 1.2×	542 1.1×	303 1.1×	46	4.5k
Sydney Gordon United States	8	1.7k 1.4×	1.4k 1.4×	740 0.8×	210 0.4×	293 1.1×	10	2.8k
Filippo Veglia United States	14	2.8k 2.2×	1.4k 1.4×	1.1k 1.1×	597 1.2×	349 1.3×	27	4.0k
Edwin Bremer Netherlands	34	1.6k 1.2×	935 0.9×	1.5k 1.6×	300 0.6×	132 0.5×	89	3.1k

Countries citing papers authored by Yong Lu

Since Specialization

Citations

This map shows the geographic impact of Yong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Lu more than expected).

Fields of papers citing papers by Yong Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Lu. The network helps show where Yong Lu may publish in the future.

Co-authorship network of co-authors of Yong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Lu. A scholar is included among the top collaborators of Yong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Lu. Yong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Liuling, Rui Duan, Chuanchao Zhang, et al.. (2025). Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss. Nature Cancer. 6(4). 718–735. 2 indexed citations

Jing, Rui, Xin Li, Ningbo Zheng, et al.. (2024). Essentials of CAR-T Therapy and Associated Microbial Challenges in Long Run Immunotherapy. PubMed. 6(1). 22–50. 1 indexed citations

Miller, Brandi, Wencheng Li, Sergey A. Krupenko, et al.. (2023). Distinct inflammatory Th17 subsets emerge in autoimmunity and infection. The Journal of Experimental Medicine. 220(10). 16 indexed citations

Soto‐Pantoja, David R., et al.. (2022). Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy. Scientific Reports. 12(1). 9983–9983. 16 indexed citations

Xue, Gang, Ziyu Wang, Ningbo Zheng, et al.. (2021). Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells. Nature Biomedical Engineering. 5(11). 1306–1319. 35 indexed citations

Liu, Yang, Lulu Wang, Qianqian Song, et al.. (2021). Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nature Nanotechnology. 17(2). 206–216. 84 indexed citations

Pullikuth, Ashok, Eric D. Routh, Kip D. Zimmerman, et al.. (2021). Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes. Frontiers in Oncology. 11. 734959–734959. 22 indexed citations

Ma, Xingzhe, Enguang Bi, Yong Lu, et al.. (2019). Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment. Cell Metabolism. 30(1). 143–156.e5. 697 indexed citations breakdown →

Xue, Gang, Guangxu Jin, Jing Fang, & Yong Lu. (2019). IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling. Nature Communications. 10(1). 1376–1376. 81 indexed citations

10.

Lu, Yong, Xiaoxue Peng, Diane Bogdan, et al.. (2018). Contribution of diacylglycerol lipase β to pain after surgery. Journal of Pain Research. Volume 11. 473–482. 9 indexed citations

11.

Lu, Yong, Michael S. Bonkowski, Michael Schultz, et al.. (2018). IN VIVO CELLULAR REPROGRAMMING FOR TISSUE REGENERATION AND AGE REVERSAL. Europe PMC (PubMed Central). 1 indexed citations

12.

Bogdan, Diane, Sang‐Hoon Park, Gregory Carbonetti, et al.. (2018). Fatty acid–binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation. Journal of Biological Chemistry. 293(14). 5295–5306. 41 indexed citations

13.

Lu, Yong, Qiang Wang, Gang Xue, et al.. (2018). Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors. Cancer Cell. 33(6). 1048–1060.e7. 121 indexed citations

14.

Kaczocha, Martin, Syed Azim, Mario J. Rebecchi, et al.. (2018). Intrathecal morphine administration reduces postoperative pain and peripheral endocannabinoid levels in total knee arthroplasty patients: a randomized clinical trial. BMC Anesthesiology. 18(1). 27–27. 19 indexed citations

15.

Galbavy, William, Yong Lu, Martin Kaczocha, et al.. (2017). Transcriptomic evidence of a para-inflammatory state in the middle aged lumbar spinal cord. Immunity & Ageing. 14(1). 9–9. 8 indexed citations

16.

Lu, Yong. (2016). The function of mechanical loading on chondrogenesis. Frontiers in bioscience. 21(6). 1222–1232. 8 indexed citations

17.

He, Jin, Zhiqiang Liu, Yuhuan Zheng, et al.. (2012). p38 MAPK in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction. Cancer Research. 72(24). 6393–6402. 69 indexed citations

18.

Zheng, Yuhuan, Jing Yang, Junyan Qian, et al.. (2012). PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma. Leukemia. 27(3). 702–710. 125 indexed citations

19.

Hong, Sungyoul, Jianfei Qian, Haiyan Li, et al.. (2011). CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma. Cancer Immunology Immunotherapy. 61(4). 561–571. 16 indexed citations

20.

Lu, Yong & Rui Zhou. (2000). [Mechanism of enhanced invasiveness of human hepatocellular carcinoma by integrin alpha 6 beta 1].. PubMed. 22(4). 287–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact